The AmoyDx® HRD Focus Panel offers dependable and cost-effective solutions for evaluating PARP inhibitor (PARPi)-related biomarkers and advancing targeted treatment research in ovarian cancer. Leveraging proprietary HANDLE technology, the Genomic Scar Score (GSS) algorithm, and the AmoyDx NGS Data Analysis System (ANDAS), the HRD Focus assay can be seamlessly integrated into your laboratory workflow.
